Nanotechnology in the programmed cell therapy: nowhere to escape of cancer

• 来源期刊: 科学通报（英文版）
• 年，卷（期）: 2016,（1）
• 页码范围: 45-47
• 页数: 3页
• 语种: 中文
• DOI: 10.1007/s11434-015-0955-0

摘要

For lymphomas,the transport of chemotherapeutic drugs usually meets physical barriers to the lymph nodes where disseminated tumor cells frequently reside.But new findings show that autologous T cells as live vectors combined with nanotechnology-based drug delivery can provide a novel opportunity for the improved chemotherapy toward lymphomas.